Florian Schonharting
Co-Founder & Non-Executive Chairman of the BoardMr. Florian Schonharting, M.Sc. (Econ), is co-Founder of GH Research PLC and has been its Non-Executive Chairman of Board since 2018. He serves as Chief Executive Officer, Co-Founder, Partner and Chief Investment Officer at NB Capital ApS. Mr. Schonharting founded Genmab A/S, during his tenure at Bankinvest. He has also founded or co-founded several other biopharmaceutical companies, Veloxis A/S (f/k/a Life Cycle Pharma A/S), Zealand Pharma A/S and Acadia Pharmaceuticals Inc. Mr. Schonharting has investment executive experience in public and private equity funds involved in the biopharmaceutical industry. He also serves as Director at Rose Pharma A/S. He serves as Director at Danish Venture Capital and Private Equity Association. He serves as Director at Biotica Technology Limited. He Co-Founded Forward Pharma A/S and serves as its Chairman since 2011 and its Director since July 2005. He previously served as Director at Curalogic A/S. He previously served as Director at Osteologix Holdings plc. He previously served as Director at Veloxis Pharmaceuticals A/S. He previously served as Director at Nuevolution A/S. Mr. Schonharting has an M.Sc. (Econ) from Copenhagen Business School.
Positions
- Company NameGH Research PLCStock CodeGHRSPositionCo-Founder & Non-Executive Chairman of the BoardColleagues
